Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis

Journal of Experimental Medicine

Volumn 191, Issue 12, 2000, Pages 2039-2051

  Legge, Kevin L ^a   Min, Booki ^a   Bell, J Jeremiah ^a   Caprio, Jacque C ^a   Li, Lequn ^a   Gregg, Randal K ^a   Zaghouani, Habib ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Antigen delivery; Autoimmunity; Bystander downregulation; Cytokine antagonism; T cell modulation

Indexed keywords

ENCEPHALITOGENIC PROTEIN; IMMUNOGLOBULIN; INTERLEUKIN 10;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; IMMUNOMODULATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; T LYMPHOCYTE;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-PRESENTING CELLS; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES; IMMUNE TOLERANCE; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-10; LIPOPROTEINS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MYELIN PROTEOLIPID PROTEIN; MYELIN SHEATH; PARALYSIS; SOLUBILITY; T-LYMPHOCYTES;

EID: 0034686434     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.12.2039     Document Type: Article

References (72)

1. Goldrath, A.W., and M.J. Bevan. 1999. Selecting and maintaining a diverse T-cell repertoire. Nature. 402:255-262.
2. Cibotti, R., J.M. Kanellopoulos, J.P. Cabaniols, O. Halle-Panenko, K. Kosmatopoulos, E. Sercarz, and P. Kourilsky. 1992. Tolerance to self-protein involves its immunodominant but does not involve its subdominant determinants. Proc. Natl. Acad. Sci. USA. 89:416-420.
3. Fowlkes, B.J., and F. Ramsdell. 1993. T-cell tolerance. Curr. Opin. Immunol. 5:873-879.
4. Herold, K.C., A.G. Montag, and F. Buckingham. 1992. Induction of tolerance to autoimmune diabetes with islet antigens. J. Exp. Med. 176:1107-1114.
5. Mamula, M.J. 1993. The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J. Exp. Med. 177:567-571.
6. Burns, J., A. Rosenzweig, B. Zweiman, and R.P. Lisak. 1983. Isolation of myelin basic protein-reactive T cell lines from normal human blood. Cell. Immunol. 81:435-440.
7. Liu, G.Y., P.J. Fairchild, R.M. Smith, J.R. Prowle, D. Kioussis, and D.C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity. 3:407-415.
8. Yan, T., H. Burkhardt, T. Ritter, B. Broker, K.H. Mann, W.M. Bertling, K. von der Mark, and F. Emmrich. 1992. Specificity and TCR β chain usage of a human collagen type II-reactive T cell clone derived from a healthy individual. Eur. J. Immunol. 22:51-56.
9. Arnold, B., G. Schonrich, and G. Hammerling. 1993. Multiple levels of peripheral tolerance. Immunol. Today. 14:12-14.
10. + T cells developing in parent F1 chimeras prepared with supralethal irradiation: step-wise induction of tolerance in the intrathymic and extrathymic environments. J. Exp. Med. 177:367-378.
11. McCormack, J.E., J.E. Callahan, J. Kappler, and P.C. Marrack. 1993. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J. Immunol. 150:3785-3792.
12. Rocha, B., and H. von Boehmer. 1991. Peripheral selection of the T cell repertoire. Science. 251:1225-1228.
13. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249-1256.
14. Jenkins, M.K., and J.G. Johnson. 1993. Molecules involved in T-cell costimulation. Curr. Opin. Immunol. 5:361-367.
15. Brocke, S., A. Gaur, C. Piercy, A. Gautam, K. Gijbels, C.G. Fathman, and L. Steinman. 1993. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature. 365:642-644.
16. Wucherpfennig, K.W., and J.L. Strominger. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
17. McRae, B.L., C.L. Vanderlugt, M.C. Dal Canto, and S.D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
18. Sercarz, E.E., P.V. Lehmann, A. Ametani, G. Benichou, A. Miller, and K. Moudgil. 1993. Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729-766.
19. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell. 85:299-302.
20. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
21. Feldmann, M., F.M. Brennan, and R.N. Maini. 1996. Rheumatoid arthritis. Cell. 85:307-310.
22. Jacobs, M.J., A.E. van den Hock, L.B. van de Putte, and W.B. van den Berg. 1994. Anergy of antigen-specific T lymphocytes is a potent mechanism of intravenously induced tolerance. Immunology. 82:294-300.
23. Mueller, D.L., and M.K. Jenkins. 1995. Molecular mechanisms underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 7:375-381.
24. Elliott, E.A., H.I. McFarland, S.H. Nye, R. Cofiell, T.M. Wilson, J.A. Wilkins, S.P. Squinto, L.A. Matis, and J.P. Mueller. 1996. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98:1602-1612.
25. Gaur, A., B. Wiers, A. Liu, J. Rothbard, and C.G. Fathman. 1992. Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science. 258:1491-1494.
26. Liblau, R., R. Tisch, N. Bercovici, and H.O. McDevitt. 1997. Systemic antigen in the treatment of T-cell-mediated autoimmune diseases. Immunol. Today. 18:599-604.
27. Mathisen, P.M., M. Yu, J.M. Johnson, J.A. Drazba, and V.K. Tuohy. 1997. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J. Exp. Med. 186:159-164.
28. Shaw, M.K., J.B. Lorens, A. Dhawan, R. DalCanto, H.Y. Tse, A.B. Tran, C. Bompane, S.L. Eswaran, S. Brocke, N. Sarvetnick, et al. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711-1714.
29. Ma, Y., S. Thornton, L.E. Duwel, G.P. Boivin, E.H. Giannini, J.M. Leiden, J.A. Bluestone, and R. Hirsch. 1998. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J. Immunol. 161:1516-1524.
30. Legge, K.L., B. Min, N.T. Potter, and H. Zaghouani. 1997. Presentation of a T cell receptor antagonist peptide by immunoglobulins ablates activation of T cells by a synthetic peptide or proteins requiring endocytic processing. J. Exp. Med. 185: 1043-1053.
31. Zaghouani, H., R. Steinman, R. Nonacs, H. Shah, W. Gerhard, and C. Bona. 1993. Presentation of a viral T cell epitope expressed in the CDR3 region of a self immunoglobulin molecule. Science. 259:224-227.
32. Deo, Y.M., R.F. Graziano, R. Repp, and J.G. van de Winkel. 1997. Clinical significance of IgG Fc receptors and FcγR-directed immunotherapies. Immunol. Today. 18:127-135.
33. Polat, G.L., J. Laufer, I. Fabian, and J.H. Passwell. 1993. Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production. Immunology. 80:287-292.
34. Sutterwala, F.S., G.J. Noel, P. Salgame, and D.M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcγ receptor type I. J. Exp. Med. 188:217-222.
35. Christian, C.L. 1960. Studies on aggregated gamma-globulin I & II. Immunol. 84:112-121.
36. Rosenqvist, E., T. Jossang, and J. Feder. 1987. Thermal properties of human IgG. Mol. Immunol. 24:495-501.
37. Tuohy, V.K., Z. Lu, R.A. Sobel, R.A. Laursen, and M.B. Lees. 1989. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142: 1523-1527.
38. Greer, J.M., V.K. Kuchroo, R.A. Sobel, and M.B. Lees. 1992. Identification and characterization of a second encephalitogenic determinant of myelin proteolipid protein (residues 178-191) for SJL mice. J. Immunol. 149:783-788.
39. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Peircy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, et al. 1996. Treatment of experimental encephalomyelitis with a peptide analog of myelin basic protein. Nature. 379:343-346.
40. Legge, K.L., B. Min, C. Pack, J. Caprio, and H. Zaghouani. 1999. Differential presentation of an altered peptide within fetal central and peripheral organs supports an avidity model for thymic cell development and implies a peripheral readjustment for activation. J. Immunol. 162:5738-5746.
41. Min, B., K.L. Legge, C. Pack, and H. Zaghouani. 1998. Neonatal exposure to a self-peptide-immunoglobulin chimera circumvents the use of adjuvant and confers resistance to autoimmune disease by a novel mechanism involving interleukin 4 lymph node deviation and interferon γ-mediated splenic anergy. J. Exp. Med. 188:2007-2017.
42. Chase, M.W., L. Gidez, L. Levine, B. Mach, W.T. Murakami, C.A. Williams. 1968. Chemical analyses. In Methods in Immunology and Immunochemistry. Vol. 2. C.A. Williams and M.W. Chase, editors. Academic Press, New York. 249-341.
43. Doyle, A.G., and I.P. Fraser. 1996. Murine macrophages: isolation, cultivation, and characterization. In Weir's Handbook of Experimental Immunology. L.A. Herzenberg, D. Weir, L.A. Herzenberg, and C. Blackwell, editors. Blackwell Science, Cambridge, MA. 154.1-154.8.
44. Romani, N., N. Bhardwaj, M. Pope, F. Koch, W.J. Swiggard, U.O. Doherty, M.D. Witmer-Pack, L. Hoffman, G. Schuler, K. Inaba, et al. 1996. Dendritic cells. In Weir's Handbook of Experimental Immunology. L.A. Herzenberg, D. Weir, L.A. Herzenberg, and C. Blackwell, editors. Blackwell Science, Cambridge, MA. 156.1-156.14.
45. Critchfield, J.M., M.K. Racke, J.C. Zuniga-Pflucker, B. Cannella, C.S. Raine, J. Goverman, and M.J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science. 263:1139-1143.
46. Chen, Y., J.I. Inobe, V.K. Kuchroo, J.L. Baron, C.A. Janeway, Jr., and H.L. Weiner. 1996. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc. Natl. Acad. Sci. USA. 93:388-391.
47. Devaux, B., F. Enderlin, B. Wallner, and D.E. Smilek. 1997. Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. J. Neuroimmunol. 75:169-173.
48. Leadbetter, E.A., C.R. Bourque, B. Devaux, C.D. Olson, G.H. Sunshine, S. Hirani, B.P. Wallner, D.E. Smilek, and M.P. Happ. 1998. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide. J. Immunol. 161:504-512.
49. Staykova, M.A., R.D. Simmons, and D.O. Willenborg. 1997. Infusion of soluble myelin basic protein protects long-term against induction of experimental autoimmune encephalomyelitis. Immunol. Cell Biol. 75:54-64.
50. Brumeanu, T.D., W.J. Swiggard, R.M. Steinman, C.A. Bona, and H. Zaghouani. 1993. Efficient loading of identical viral peptide onto class II molecules by antigenized immunoglobulin and influenza virus. J. Exp. Med. 178:1795-1799.
51. Berger, S., H. Ballo, and H.J. Stutte. 1996. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: a network of pro- and anti-inflammatory cytokines dependent on the antigen:antibody ratio. Eur. J. Immunol. 26:1297-1301.
52. Berger, S., R. Chandra, H. Ballo, R. Hildenbrand, and H.J. Stutte. 1997. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes. Eur. J. Immunol. 27:2994-3000.
53. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A.H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772-4780.
54. Ding, L., P.S. Linsley, L.-Y. Huang, R.N. Germain, and E.M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
55. Fiorentino, D.F., A. Zlotnik, P. Vieira, T.R. Mosmann, M. Howard, K.W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
56. Falcone, M., and B.R. Bloom. 1997. A T helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med. 185:901-907.
57. Stohlman, S.A., L. Pei, D.J. Cua, Z. Li, and D. Hinton. 1999. Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10. J. Immunol. 163:6338-6344.
58. Tuohy, V.K., M. Yu, J.A. Kawczak, J.M. Johnson, P.M. Mathisen, B. Weinstock-Guttman, and R.P. Kinkel. 1998. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164:93-100.
59. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J.E. de Vries, and M.G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
60. Asseman, C., S. Mauze, M.W. Leach, R.L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995-1003.
61. Groux, H., and F. Powrie. 1999. Regulatory T cells and inflammatory bowel disease. Immunol. Today. 20:442-445.
62. Seddon, B., and D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189:877-881.
63. Seddon, B., and D. Mason. 2000. The third function of the thymus. Immunol. Today. 21:95-99.
64. Legge, K.L., B. Min, A.E. Cestra, C.D. Pack, and H. Zaghouani. 1998. TCR agonist and antagonist exert in vivo cross-regulation when presented on Igs. J. Immunol. 161:106-111.
65. Cannella, B., Y.L. Gao, C. Brosnan, and C.S. Raine. 1996. IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:735-746.
66. Cua, D.J., H. Groux, D.R. Hinton, S.A. Stohlman, and R.L. Coffman. 1999. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 189:1005-1010.
67. Chang, J.T., E.M. Shevach, and B.M. Segal. 1999. Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J. Exp. Med. 189:969-978.
68. Grewal, I.S., and R.A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111-135.
69. Stuber, E., W. Strober, and M. Neurath. 1996. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183:693-698.
70. Jerne, N.K. 1974. Towards a network theory of the immune system. Ann. Immunol. (Paris). 125C:373-389.
71. Anderson, A.C., L.B. Nicholson, K.L. Legge, V. Turchin, H. Zaghouani, and V.K. Kuchroo. 2000. High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire. J. Exp. Med. 191:761-770.
72. Stinissen, P., J. Raus, and J. Zhang. 1997. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit. Rev. Immunol. 17:33-75.